Active substances

Artemether + lumefantrine›

P01BF01 Antiparasitic products, insecticides and repellents | Antimalarials | Artemisinin and derivatives, combinations

Indicated for: malaria

Artesunate›

P01BE03 Antiparasitic products, insecticides and repellents | Antimalarials | Artemisinin and derivatives, plain

Indicated for: malaria

Articaine + adrenaline›

N01BB58 Nervous system | Anesthetics | Anesthetics, local | Amides

Indicated for: local anesthesia

Artichoke extract›

A05AXN1 Alimentary tract and metabolism | Bile therapy | Other drugs for bile therapy

Indicated for: traditional relief of dyspepsia, fullness, bloating and flatulence

Asciminib›

L01EA06 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Indicated for: chronic myeloid leukemia

Ascorbic acid›

A11GA01 Alimentary tract and metabolism | Ascorbic acid (vitamin C), incl. combinations | Ascorbic acid (vitamin C), plain

Indicated for: vitamin deficiency

Ascorbic acid + tocopherol + beta-carotene + selenium›

A11JBN1 Alimentary tract and metabolism | Other vitamin products, combinations | Vitamins with minerals

Indicated for: vitamin and selenium deficiency; antioxidant supplementation

Asenapine›

N05AH05 Nervous system | Antipsychotics | Diazepines, oxazepines, thiazepines and oxepines

Indicated for: schizophrenia; bipolar disorder

Asfotase alfa›

A16AB13 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes

Indicated for: hypophosphatasia

Asparaginase›

L01XX02 Antineoplastic and immunomodulating agents | Other antineoplastic agents

Indicated for: leukemia

Aspartic acid + pyridoxine›

A05BAN3 Alimentary tract and metabolism | Liver therapy, lipotropics

Indicated for: asthenia; vitamin B6 deficiency

Ataluren›

M09AX03 Musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system

Indicated for: Duchenne muscular dystrophy

Atazanavir›

J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors

Indicated for: HIV-1 infection

Atazanavir + cobicistat›

J05AR15 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations

Indicated for: HIV-1 infection

Atenolol›

C07AB03 Cardiovascular system | Beta blocking agents | Beta blocking agents | Beta blocking agents, selective

Indicated for: hypertension; angina pectoris

Atezolizumab›

L01FF05 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors

Indicated for: cancer

Atogepant›

N02CD07 Nervous system | Antimigraine preparations | Calcitonin gene-related peptide (CGRP) antagonists

Indicated for: migraine

Atomoxetine›

N06BA09 Nervous system | Psychostimulants, agents used for adhd and nootropics | Centrally acting sympathomimetics

Indicated for: attention deficit hyperactivity disorder (ADHD)

Atorvastatin›

C10AA05 Cardiovascular system | Lipid modifying agents | Lipid modifying agents, plain | Hmg coa reductase inhibitors

Indicated for: dyslipidemia

Atorvastatin + amlodipine›

C10BX03 Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs

Indicated for: dyslipidemia; hypertension

Atorvastatin + ezetimibe›

C10BA05 Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Combinations of various lipid modifying agents

Indicated for: dyslipidemia

Atorvastatin + perindopril›

C10BX15 Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs

Indicated for: dyslipidemia; hypertension

Atorvastatin + perindopril + amlodipine›

C10BX11 Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs

Indicated for: dyslipidemia; hypertension

Atosiban›

G02CX01 Genito urinary system and sex hormones | Other gynecologicals | Other gynecologicals

Indicated for: delay of preterm labor

Atovaquone + proguanil›

P01BB51 Antiparasitic products, insecticides and repellents | Antimalarials | Biguanides

Indicated for: malaria

Atracurium›

M03AC04 Musculo-skeletal system | Muscle relaxants | Muscle relaxants, peripherally acting agents | Other quaternary ammonium compounds

Indicated for: muscle relaxation in anesthesia

Atropine›

A03BA01 Alimentary tract and metabolism | Belladonna and derivatives, plain | Belladonna alkaloids, tertiary amines

Indicated for: bradycardia; antidote in cholinergic poisoning

Atropine sulfate + ergoton + propranolol + amobarbital sodium›

C07NAN1 Cardiovascular system |

Indicated for: hypertension

Autologous human cartilaginous cells›

M09AX02 Musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system

Indicated for: articular cartilage defects

Avacopan›

L04AJ05 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Complement inhibitors

Indicated for: ANCA-associated vasculitis